際際滷shows by User: robertoscarafia / http://www.slideshare.net/images/logo.gif 際際滷shows by User: robertoscarafia / Mon, 21 May 2018 08:25:48 GMT 際際滷Share feed for 際際滷shows by User: robertoscarafia 20180515 toma privacy gdpr ver10 definitiva parte 1 /slideshow/20180515-toma-privacy-gdpr-ver10-definitiva-parte-1/97838542 20180515tomaprivacygdprver10definitivaparte1-180521082548
IMPLEMENTAZIONE PRESSO LA TOMA ADVANCED BIOMEDICAL ASSAYS DEL NUOVO DISPOSTO NORMATIVO SULLA TUTELA DELLA PRIVACY E TRATTAMENTO DATI SENSIBILI Il presente documento e finalizzato ad individuare e stabilire le misure di sicurezza organizzative, fisiche e logiche, inerenti le attivita aziendali, nel rispetto del disposto normativo di prossimo entrata in vigore (25 maggio 2018) affinche le stesse siano adottate e siano rispettati gli obblighi, in materia di tutela della privacy e di sicurezza del trattamento dei dati previsto dal ilRegolamento Ue 2016/679,noto come GDPR (General Data Protection Regulation relativo alla protezione delle persone fisiche con riguardo al trattamento e alla libera circolazione dei dati personali: legge 20 novembre 2017, n. 167 in vigore dal 12 dicembre p.v.) ]]>
IMPLEMENTAZIONE PRESSO LA TOMA ADVANCED BIOMEDICAL ASSAYS DEL NUOVO DISPOSTO NORMATIVO SULLA TUTELA DELLA PRIVACY E TRATTAMENTO DATI SENSIBILI Il presente documento e finalizzato ad individuare e stabilire le misure di sicurezza organizzative, fisiche e logiche, inerenti le attivita aziendali, nel rispetto del disposto normativo di prossimo entrata in vigore (25 maggio 2018) affinche le stesse siano adottate e siano rispettati gli obblighi, in materia di tutela della privacy e di sicurezza del trattamento dei dati previsto dal ilRegolamento Ue 2016/679,noto come GDPR (General Data Protection Regulation relativo alla protezione delle persone fisiche con riguardo al trattamento e alla libera circolazione dei dati personali: legge 20 novembre 2017, n. 167 in vigore dal 12 dicembre p.v.) ]]> Mon, 21 May 2018 08:25:48 GMT /slideshow/20180515-toma-privacy-gdpr-ver10-definitiva-parte-1/97838542 robertoscarafia@slideshare.net(robertoscarafia) 20180515 toma privacy gdpr ver10 definitiva parte 1 robertoscarafia IMPLEMENTAZIONE PRESSO LA TOMA ADVANCED BIOMEDICAL ASSAYS DEL NUOVO DISPOSTO NORMATIVO SULLA TUTELA DELLA PRIVACY E TRATTAMENTO DATI SENSIBILI Il presente documento e finalizzato ad individuare e stabilire le misure di sicurezza organizzative, fisiche e logiche, inerenti le attivita aziendali, nel rispetto del disposto normativo di prossimo entrata in vigore (25 maggio 2018) affinche le stesse siano adottate e siano rispettati gli obblighi, in materia di tutela della privacy e di sicurezza del trattamento dei dati previsto dal ilRegolamento Ue 2016/679,noto come GDPR (General Data Protection Regulation relativo alla protezione delle persone fisiche con riguardo al trattamento e alla libera circolazione dei dati personali: legge 20 novembre 2017, n. 167 in vigore dal 12 dicembre p.v.) <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/20180515tomaprivacygdprver10definitivaparte1-180521082548-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> IMPLEMENTAZIONE PRESSO LA TOMA ADVANCED BIOMEDICAL ASSAYS DEL NUOVO DISPOSTO NORMATIVO SULLA TUTELA DELLA PRIVACY E TRATTAMENTO DATI SENSIBILI Il presente documento e finalizzato ad individuare e stabilire le misure di sicurezza organizzative, fisiche e logiche, inerenti le attivita aziendali, nel rispetto del disposto normativo di prossimo entrata in vigore (25 maggio 2018) affinche le stesse siano adottate e siano rispettati gli obblighi, in materia di tutela della privacy e di sicurezza del trattamento dei dati previsto dal ilRegolamento Ue 2016/679,noto come GDPR (General Data Protection Regulation relativo alla protezione delle persone fisiche con riguardo al trattamento e alla libera circolazione dei dati personali: legge 20 novembre 2017, n. 167 in vigore dal 12 dicembre p.v.)
20180515 toma privacy gdpr ver10 definitiva parte 1 from ToMa Advanced Biomedical Assays Spa
]]> 194 1 https://cdn.slidesharecdn.com/ss_thumbnails/20180515tomaprivacygdprver10definitivaparte1-180521082548-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 20180426 presentation to-personnel-v3.pptx /slideshow/20180426-presentation-topersonnelv3pptx-97836493/97836493 20180426presentation-to-personnel-v3-180521080842
GDPR - nuova privacy - Laboratorio Genetica Adempimenti form template]]>
GDPR - nuova privacy - Laboratorio Genetica Adempimenti form template]]> Mon, 21 May 2018 08:08:42 GMT /slideshow/20180426-presentation-topersonnelv3pptx-97836493/97836493 robertoscarafia@slideshare.net(robertoscarafia) 20180426 presentation to-personnel-v3.pptx robertoscarafia GDPR - nuova privacy - Laboratorio Genetica Adempimenti form template <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/20180426presentation-to-personnel-v3-180521080842-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> GDPR - nuova privacy - Laboratorio Genetica Adempimenti form template
20180426 presentation to-personnel-v3.pptx from ToMa Advanced Biomedical Assays Spa
]]> 18 1 https://cdn.slidesharecdn.com/ss_thumbnails/20180426presentation-to-personnel-v3-180521080842-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Biocell teaser 2 2014 - Roberto Scarafia rscarafia@tomalab.com /slideshow/biocell-teaser-2-2014-roberto-scarafia-rscarafiatomalabcom/86141637 20140211biocellteaser2-2014-180114205938
Prenatal stem cells - at the forefront of science - Business OpportunityAmniotic Fluid and CHORIONIC VILLI Stem Cells amniotic fluid and chorionic villi represent a new source of stem cells that could have applications in tissue engineering and cell therapy, in particular in prenatal congenital pathologies [1] International studies have demonstrated that Amniotic Fluid and Chorionic villi are the richest sources for Mesenchymal Stem Cells ; Mesenchymal Stem Cells are the progenitors of Muscles, Bones, Cartilages, Neurons, Liver cells, Renal cells and Hemopoietic cells ; Biocell Center has developed and patented methods for processing and preserving stem cells from the Amniotic Fluid and Chorionic Villi in GMP conditions; Biocell Center works with mothers and doctors to cryo-preserve (freeze) small aliquotes of Amniotic Fluid or Chorionic Villi, that are collected during amniocentesis and CVS procedures, or at birth, by collecting the placenta and processing it, without increasing the risk to the patient or fetus. ]]>
Prenatal stem cells - at the forefront of science - Business OpportunityAmniotic Fluid and CHORIONIC VILLI Stem Cells amniotic fluid and chorionic villi represent a new source of stem cells that could have applications in tissue engineering and cell therapy, in particular in prenatal congenital pathologies [1] International studies have demonstrated that Amniotic Fluid and Chorionic villi are the richest sources for Mesenchymal Stem Cells ; Mesenchymal Stem Cells are the progenitors of Muscles, Bones, Cartilages, Neurons, Liver cells, Renal cells and Hemopoietic cells ; Biocell Center has developed and patented methods for processing and preserving stem cells from the Amniotic Fluid and Chorionic Villi in GMP conditions; Biocell Center works with mothers and doctors to cryo-preserve (freeze) small aliquotes of Amniotic Fluid or Chorionic Villi, that are collected during amniocentesis and CVS procedures, or at birth, by collecting the placenta and processing it, without increasing the risk to the patient or fetus. ]]> Sun, 14 Jan 2018 20:59:38 GMT /slideshow/biocell-teaser-2-2014-roberto-scarafia-rscarafiatomalabcom/86141637 robertoscarafia@slideshare.net(robertoscarafia) Biocell teaser 2 2014 - Roberto Scarafia rscarafia@tomalab.com robertoscarafia Prenatal stem cells - at the forefront of science - Business Opportunity鐃Amniotic Fluid and CHORIONIC VILLI Stem Cells amniotic fluid and chorionic villi represent a new source of stem cells that could have applications in tissue engineering and cell therapy, in particular in prenatal congenital pathologies [1] International studies have demonstrated that Amniotic Fluid and Chorionic villi are the richest sources for Mesenchymal Stem Cells ; Mesenchymal Stem Cells are the progenitors of Muscles, Bones, Cartilages, Neurons, Liver cells, Renal cells and Hemopoietic cells ; Biocell Center has developed and patented methods for processing and preserving stem cells from the Amniotic Fluid and Chorionic Villi in GMP conditions; Biocell Center works with mothers and doctors to cryo-preserve (freeze) small aliquotes of Amniotic Fluid or Chorionic Villi, that are collected during amniocentesis and CVS procedures, or at birth, by collecting the placenta and processing it, without increasing the risk to the patient or fetus. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/20140211biocellteaser2-2014-180114205938-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Prenatal stem cells - at the forefront of science - Business Opportunity鐃Amniotic Fluid and CHORIONIC VILLI Stem Cells amniotic fluid and chorionic villi represent a new source of stem cells that could have applications in tissue engineering and cell therapy, in particular in prenatal congenital pathologies [1] International studies have demonstrated that Amniotic Fluid and Chorionic villi are the richest sources for Mesenchymal Stem Cells ; Mesenchymal Stem Cells are the progenitors of Muscles, Bones, Cartilages, Neurons, Liver cells, Renal cells and Hemopoietic cells ; Biocell Center has developed and patented methods for processing and preserving stem cells from the Amniotic Fluid and Chorionic Villi in GMP conditions; Biocell Center works with mothers and doctors to cryo-preserve (freeze) small aliquotes of Amniotic Fluid or Chorionic Villi, that are collected during amniocentesis and CVS procedures, or at birth, by collecting the placenta and processing it, without increasing the risk to the patient or fetus.
Biocell teaser 2 2014 - Roberto Scarafia rscarafia@tomalab.com from ToMa Advanced Biomedical Assays Spa
]]> 244 2 https://cdn.slidesharecdn.com/ss_thumbnails/20140211biocellteaser2-2014-180114205938-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 20121027 Form 231/01 - ODV - Rules - Italy /slideshow/20121027-form-23101-odv-rules-italy/85841762 20121027form231-01-180108060511
It is a Legislative decree no. 231 of 8 June 2001 "Provisions governing administrative liability of legal entities, companies and associations, including those lacking legal personality" ("Legislation 231"), governs the liability of entities for administrative unlawful acts in connection with relevant crimes. Administrative Liability Under Legislation 231, ToMa spa Lab may be held liable for certain crimes committed or attempted in its interest or for its benefit, by top level executives/officers or their subordinates. It follows that oMa spa Lab is subject, on a direct and autonomous basis, to certain administrative sanctions in connection with relevant crimes attributable to the above-mentioned individuals. Administrative liability for the Research Center as the Diagnostic Institute is, however, excluded where the ToMaLab has, inter alia, adopted and effectively implemented, prior to the commitment of the relevant crimes a suitable Organisational, Management and Control Model (the "Model"). Further, it should be noted that ToMa spa Lab will not be liable, pursuant to the express provisions of Legislation 231, if the top level executives/officers and/or their subordinates acted exclusively in their own interest or in the interest of third parties. Administrative responsibility, where applicable, is additional to the criminal responsibility for the perpetrators of relevant crimes. In the light of the above, the Legal Representative of ToMa spa Lab has appointed three members representative of the structure of the Company and who possess the necessary integrity and subjective requirements. The ODV has s reporting system which ensures that it receives the following information flows: Any action or omission deemed in good faith not to be in compliance with the Model; Any circumstance in which it is deemed in good faith that a relevant offence or crime may be committed.]]>
It is a Legislative decree no. 231 of 8 June 2001 "Provisions governing administrative liability of legal entities, companies and associations, including those lacking legal personality" ("Legislation 231"), governs the liability of entities for administrative unlawful acts in connection with relevant crimes. Administrative Liability Under Legislation 231, ToMa spa Lab may be held liable for certain crimes committed or attempted in its interest or for its benefit, by top level executives/officers or their subordinates. It follows that oMa spa Lab is subject, on a direct and autonomous basis, to certain administrative sanctions in connection with relevant crimes attributable to the above-mentioned individuals. Administrative liability for the Research Center as the Diagnostic Institute is, however, excluded where the ToMaLab has, inter alia, adopted and effectively implemented, prior to the commitment of the relevant crimes a suitable Organisational, Management and Control Model (the "Model"). Further, it should be noted that ToMa spa Lab will not be liable, pursuant to the express provisions of Legislation 231, if the top level executives/officers and/or their subordinates acted exclusively in their own interest or in the interest of third parties. Administrative responsibility, where applicable, is additional to the criminal responsibility for the perpetrators of relevant crimes. In the light of the above, the Legal Representative of ToMa spa Lab has appointed three members representative of the structure of the Company and who possess the necessary integrity and subjective requirements. The ODV has s reporting system which ensures that it receives the following information flows: Any action or omission deemed in good faith not to be in compliance with the Model; Any circumstance in which it is deemed in good faith that a relevant offence or crime may be committed.]]> Mon, 08 Jan 2018 06:05:11 GMT /slideshow/20121027-form-23101-odv-rules-italy/85841762 robertoscarafia@slideshare.net(robertoscarafia) 20121027 Form 231/01 - ODV - Rules - Italy robertoscarafia It is a Legislative decree no. 231 of 8 June 2001 "Provisions governing administrative liability of legal entities, companies and associations, including those lacking legal personality" ("Legislation 231"), governs the liability of entities for administrative unlawful acts in connection with relevant crimes. Administrative Liability Under Legislation 231, ToMa spa Lab may be held liable for certain crimes committed or attempted in its interest or for its benefit, by top level executives/officers or their subordinates. It follows that oMa spa Lab is subject, on a direct and autonomous basis, to certain administrative sanctions in connection with relevant crimes attributable to the above-mentioned individuals. Administrative liability for the Research Center as the Diagnostic Institute is, however, excluded where the ToMaLab has, inter alia, adopted and effectively implemented, prior to the commitment of the relevant crimes a suitable Organisational, Management and Control Model (the "Model"). Further, it should be noted that ToMa spa Lab will not be liable, pursuant to the express provisions of Legislation 231, if the top level executives/officers and/or their subordinates acted exclusively in their own interest or in the interest of third parties. Administrative responsibility, where applicable, is additional to the criminal responsibility for the perpetrators of relevant crimes. In the light of the above, the Legal Representative of ToMa spa Lab has appointed three members representative of the structure of the Company and who possess the necessary integrity and subjective requirements. The ODV has s reporting system which ensures that it receives the following information flows: Any action or omission deemed in good faith not to be in compliance with the Model; Any circumstance in which it is deemed in good faith that a relevant offence or crime may be committed. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/20121027form231-01-180108060511-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> It is a Legislative decree no. 231 of 8 June 2001 &quot;Provisions governing administrative liability of legal entities, companies and associations, including those lacking legal personality&quot; (&quot;Legislation 231&quot;), governs the liability of entities for administrative unlawful acts in connection with relevant crimes. Administrative Liability Under Legislation 231, ToMa spa Lab may be held liable for certain crimes committed or attempted in its interest or for its benefit, by top level executives/officers or their subordinates. It follows that oMa spa Lab is subject, on a direct and autonomous basis, to certain administrative sanctions in connection with relevant crimes attributable to the above-mentioned individuals. Administrative liability for the Research Center as the Diagnostic Institute is, however, excluded where the ToMaLab has, inter alia, adopted and effectively implemented, prior to the commitment of the relevant crimes a suitable Organisational, Management and Control Model (the &quot;Model&quot;). Further, it should be noted that ToMa spa Lab will not be liable, pursuant to the express provisions of Legislation 231, if the top level executives/officers and/or their subordinates acted exclusively in their own interest or in the interest of third parties. Administrative responsibility, where applicable, is additional to the criminal responsibility for the perpetrators of relevant crimes. In the light of the above, the Legal Representative of ToMa spa Lab has appointed three members representative of the structure of the Company and who possess the necessary integrity and subjective requirements. The ODV has s reporting system which ensures that it receives the following information flows: Any action or omission deemed in good faith not to be in compliance with the Model; Any circumstance in which it is deemed in good faith that a relevant offence or crime may be committed.
20121027 Form 231/01 - ODV - Rules - Italy from ToMa Advanced Biomedical Assays Spa
]]> 78 2 https://cdn.slidesharecdn.com/ss_thumbnails/20121027form231-01-180108060511-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Cf dna for fetal aneuploidy risk assessment toma sept 2015 usb /slideshow/cf-dna-for-fetal-aneuploidy-risk-assessment-toma-sept-2015-usb/85830857 cfdnaforfetalaneuploidyriskassessmenttomasept2015usb-180107221424
dna for fetal aneuploidy risk assessment]]>
dna for fetal aneuploidy risk assessment]]> Sun, 07 Jan 2018 22:14:24 GMT /slideshow/cf-dna-for-fetal-aneuploidy-risk-assessment-toma-sept-2015-usb/85830857 robertoscarafia@slideshare.net(robertoscarafia) Cf dna for fetal aneuploidy risk assessment toma sept 2015 usb robertoscarafia dna for fetal aneuploidy risk assessment <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/cfdnaforfetalaneuploidyriskassessmenttomasept2015usb-180107221424-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> dna for fetal aneuploidy risk assessment
Cf dna for fetal aneuploidy risk assessment toma sept 2015 usb from ToMa Advanced Biomedical Assays Spa
]]> 200 3 https://cdn.slidesharecdn.com/ss_thumbnails/cfdnaforfetalaneuploidyriskassessmenttomasept2015usb-180107221424-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 20160218 hisham toma services /slideshow/20160218-hisham-toma-services/85830752 20160218hishamtomaservices-180107221105
NSA Diagnostic Laboratory has been operating since 1958, founded by Prof. Nasseh Amin. NSA is considered as one of the most advanced labs in Egypt. Maintaining personalized services for its stakeholders, as well as the main role of the lab "Diagnosis" NSA Diagnostic Laboratory operates through two different segments. Firstly, a group of stand-alone labs located at prime locations all over Egypt, with the latest and up to date equipments. Secondly, being the backbone of well reputed hospitals and some polyclinics where NSA is the lab that is responsible for all medical testing there, serving all our patients with class A quality. Our main focus is delivering quality care and with Cost-value return. NSA plays a key role in improving the health of many Egyptians, by providing access to quality service for more than 200,000 patients annually.]]>
NSA Diagnostic Laboratory has been operating since 1958, founded by Prof. Nasseh Amin. NSA is considered as one of the most advanced labs in Egypt. Maintaining personalized services for its stakeholders, as well as the main role of the lab "Diagnosis" NSA Diagnostic Laboratory operates through two different segments. Firstly, a group of stand-alone labs located at prime locations all over Egypt, with the latest and up to date equipments. Secondly, being the backbone of well reputed hospitals and some polyclinics where NSA is the lab that is responsible for all medical testing there, serving all our patients with class A quality. Our main focus is delivering quality care and with Cost-value return. NSA plays a key role in improving the health of many Egyptians, by providing access to quality service for more than 200,000 patients annually.]]> Sun, 07 Jan 2018 22:11:05 GMT /slideshow/20160218-hisham-toma-services/85830752 robertoscarafia@slideshare.net(robertoscarafia) 20160218 hisham toma services robertoscarafia NSA Diagnostic Laboratory has been operating since 1958, founded by Prof. Nasseh Amin. NSA is considered as one of the most advanced labs in Egypt. Maintaining personalized services for its stakeholders, as well as the main role of the lab "Diagnosis" NSA Diagnostic Laboratory operates through two different segments. Firstly, a group of stand-alone labs located at prime locations all over Egypt, with the latest and up to date equipments. Secondly, being the backbone of well reputed hospitals and some polyclinics where NSA is the lab that is responsible for all medical testing there, serving all our patients with class A quality. Our main focus is delivering quality care and with Cost-value return. NSA plays a key role in improving the health of many Egyptians, by providing access to quality service for more than 200,000 patients annually. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/20160218hishamtomaservices-180107221105-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> NSA Diagnostic Laboratory has been operating since 1958, founded by Prof. Nasseh Amin. NSA is considered as one of the most advanced labs in Egypt. Maintaining personalized services for its stakeholders, as well as the main role of the lab &quot;Diagnosis&quot; NSA Diagnostic Laboratory operates through two different segments. Firstly, a group of stand-alone labs located at prime locations all over Egypt, with the latest and up to date equipments. Secondly, being the backbone of well reputed hospitals and some polyclinics where NSA is the lab that is responsible for all medical testing there, serving all our patients with class A quality. Our main focus is delivering quality care and with Cost-value return. NSA plays a key role in improving the health of many Egyptians, by providing access to quality service for more than 200,000 patients annually.
20160218 hisham toma services from ToMa Advanced Biomedical Assays Spa
]]> 97 1 https://cdn.slidesharecdn.com/ss_thumbnails/20160218hishamtomaservices-180107221105-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 20160120 biocell center corp b2 b /slideshow/20160120-biocell-center-corp-b2-b/85830658 20160120biocellcentercorpb2b-180107220529
Biocell Center is the first company in the world to cryo-preserve stem cells collected from amniotic fluid and chorionic villi. Managed by an extraordinary team of scientists, biologists, and geneticists, Biocell Center operates all over the world offering to selected partner services of its cryobanks and licensing of its own patents. These services include cryobanks of amniotic fluid, chorionic villi, placenta, cord tissue, dental teeth stem cells and amniotic membrane. The company headquarter is located in Contone (CH) and Biocell Center owns laboratories and cryobanks in Switzerland, United States and Italy. PLACENTAL STEM CELLS When you are cryo-preserving the placental stem cells of your baby you are protecting them in the safest way for his/her safety, while doing so in the most efficient way. This important biological heritage has a strong potential that can not only be used in clinical trials as today, but also in the future when your baby will be older and scientific research will be more advanced. Placental stem cells have high differentiation and proliferation rates: this is indeed a biological heritage that has to be kept safe through the efficient and convenient method that was developed thanks to Biocell Centers technology. Our children are the most important joy that the Earth gives us and we now give them an extra chance with a very high quality service (according to US highest standards) and competitive costs.]]>
Biocell Center is the first company in the world to cryo-preserve stem cells collected from amniotic fluid and chorionic villi. Managed by an extraordinary team of scientists, biologists, and geneticists, Biocell Center operates all over the world offering to selected partner services of its cryobanks and licensing of its own patents. These services include cryobanks of amniotic fluid, chorionic villi, placenta, cord tissue, dental teeth stem cells and amniotic membrane. The company headquarter is located in Contone (CH) and Biocell Center owns laboratories and cryobanks in Switzerland, United States and Italy. PLACENTAL STEM CELLS When you are cryo-preserving the placental stem cells of your baby you are protecting them in the safest way for his/her safety, while doing so in the most efficient way. This important biological heritage has a strong potential that can not only be used in clinical trials as today, but also in the future when your baby will be older and scientific research will be more advanced. Placental stem cells have high differentiation and proliferation rates: this is indeed a biological heritage that has to be kept safe through the efficient and convenient method that was developed thanks to Biocell Centers technology. Our children are the most important joy that the Earth gives us and we now give them an extra chance with a very high quality service (according to US highest standards) and competitive costs.]]> Sun, 07 Jan 2018 22:05:29 GMT /slideshow/20160120-biocell-center-corp-b2-b/85830658 robertoscarafia@slideshare.net(robertoscarafia) 20160120 biocell center corp b2 b robertoscarafia Biocell Center is the first company in the world to cryo-preserve stem cells collected from amniotic fluid and chorionic villi. Managed by an extraordinary team of scientists, biologists, and geneticists, Biocell Center operates all over the world offering to selected partner services of its cryobanks and licensing of its own patents. These services include cryobanks of amniotic fluid, chorionic villi, placenta, cord tissue, dental teeth stem cells and amniotic membrane. The company headquarter is located in Contone (CH) and Biocell Center owns laboratories and cryobanks in Switzerland, United States and Italy. PLACENTAL STEM CELLS When you are cryo-preserving the placental stem cells of your baby you are protecting them in the safest way for his/her safety, while doing so in the most efficient way. This important biological heritage has a strong potential that can not only be used in clinical trials as today, but also in the future when your baby will be older and scientific research will be more advanced. Placental stem cells have high differentiation and proliferation rates: this is indeed a biological heritage that has to be kept safe through the efficient and convenient method that was developed thanks to Biocell Centers technology. Our children are the most important joy that the Earth gives us and we now give them an extra chance with a very high quality service (according to US highest standards) and competitive costs. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/20160120biocellcentercorpb2b-180107220529-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Biocell Center is the first company in the world to cryo-preserve stem cells collected from amniotic fluid and chorionic villi. Managed by an extraordinary team of scientists, biologists, and geneticists, Biocell Center operates all over the world offering to selected partner services of its cryobanks and licensing of its own patents. These services include cryobanks of amniotic fluid, chorionic villi, placenta, cord tissue, dental teeth stem cells and amniotic membrane. The company headquarter is located in Contone (CH) and Biocell Center owns laboratories and cryobanks in Switzerland, United States and Italy. PLACENTAL STEM CELLS When you are cryo-preserving the placental stem cells of your baby you are protecting them in the safest way for his/her safety, while doing so in the most efficient way. This important biological heritage has a strong potential that can not only be used in clinical trials as today, but also in the future when your baby will be older and scientific research will be more advanced. Placental stem cells have high differentiation and proliferation rates: this is indeed a biological heritage that has to be kept safe through the efficient and convenient method that was developed thanks to Biocell Centers technology. Our children are the most important joy that the Earth gives us and we now give them an extra chance with a very high quality service (according to US highest standards) and competitive costs.
20160120 biocell center corp b2 b from ToMa Advanced Biomedical Assays Spa
]]> 169 1 https://cdn.slidesharecdn.com/ss_thumbnails/20160120biocellcentercorpb2b-180107220529-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Myriad corporate presentation toma january 2011 /slideshow/myriad-corporate-presentation-toma-january-2011/85830356 6a-20110110myriadcorporatepresentationtomajanuary2011-180107215042
nside Myriad. At Myriad, our goal is to make a difference in patients' lives and our work has been guided by this mission throughout the Company's history. ... Since 1991, Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease.]]>
nside Myriad. At Myriad, our goal is to make a difference in patients' lives and our work has been guided by this mission throughout the Company's history. ... Since 1991, Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease.]]> Sun, 07 Jan 2018 21:50:42 GMT /slideshow/myriad-corporate-presentation-toma-january-2011/85830356 robertoscarafia@slideshare.net(robertoscarafia) Myriad corporate presentation toma january 2011 robertoscarafia nside Myriad. At Myriad, our goal is to make a difference in patients' lives and our work has been guided by this mission throughout the Company's history. ... Since 1991, Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/6a-20110110myriadcorporatepresentationtomajanuary2011-180107215042-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> nside Myriad. At Myriad, our goal is to make a difference in patients&#39; lives and our work has been guided by this mission throughout the Company&#39;s history. ... Since 1991, Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease.
Myriad corporate presentation toma january 2011 from ToMa Advanced Biomedical Assays Spa
]]> 117 3 https://cdn.slidesharecdn.com/ss_thumbnails/6a-20110110myriadcorporatepresentationtomajanuary2011-180107215042-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 NSA cell safe presentation /robertoscarafia/nsa-cell-safe-presentation 20091207nsacellsafepresentation-180107214615
At Cell Safe Cord Blood Bank our mission is to give families hope for longer, healthier lives. We see a day when saving newborn stem cells will be a routine practice and stem cell therapy will be the first line of treatment for many of today's incurable diseases & injuries. Our primary responsibility is to serve - families that have chosen us to be a partner in their future health. We are committed to the families that have entrusted us with their newborn's stem cells and provide the protection and peace of mind that comes from a relentless focus on quality and innovation in our services. ]]>
At Cell Safe Cord Blood Bank our mission is to give families hope for longer, healthier lives. We see a day when saving newborn stem cells will be a routine practice and stem cell therapy will be the first line of treatment for many of today's incurable diseases & injuries. Our primary responsibility is to serve - families that have chosen us to be a partner in their future health. We are committed to the families that have entrusted us with their newborn's stem cells and provide the protection and peace of mind that comes from a relentless focus on quality and innovation in our services. ]]> Sun, 07 Jan 2018 21:46:15 GMT /robertoscarafia/nsa-cell-safe-presentation robertoscarafia@slideshare.net(robertoscarafia) NSA cell safe presentation robertoscarafia At Cell Safe Cord Blood Bank our mission is to give families hope for longer, healthier lives. We see a day when saving newborn stem cells will be a routine practice and stem cell therapy will be the first line of treatment for many of today's incurable diseases & injuries. Our primary responsibility is to serve - families that have chosen us to be a partner in their future health. We are committed to the families that have entrusted us with their newborn's stem cells and provide the protection and peace of mind that comes from a relentless focus on quality and innovation in our services. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/20091207nsacellsafepresentation-180107214615-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> At Cell Safe Cord Blood Bank our mission is to give families hope for longer, healthier lives. We see a day when saving newborn stem cells will be a routine practice and stem cell therapy will be the first line of treatment for many of today&#39;s incurable diseases &amp; injuries. Our primary responsibility is to serve - families that have chosen us to be a partner in their future health. We are committed to the families that have entrusted us with their newborn&#39;s stem cells and provide the protection and peace of mind that comes from a relentless focus on quality and innovation in our services.
NSA cell safe presentation from ToMa Advanced Biomedical Assays Spa
]]> 102 1 https://cdn.slidesharecdn.com/ss_thumbnails/20091207nsacellsafepresentation-180107214615-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Pdpdp /slideshow/pdpdp/85829745 pdpdp-180107212157
P.D.P.D.P. PARTIAL DIAGNOSTIC PROCESS DELOCALISATION PROJECT TRANSPORT OF HUMAN BIOLOGICAL SAMPLES HIGH COST & DEPERIBILITY ANALYSIS Business develoment prospective Parziale Delocalizzazione Produttiva prodotti\servizi a cui e applicabile modalita operative A quali prodotti\servizi e applicabile. La delocalizzazione produttiva e applicabile ad ogni prodotto\servizio finito\semi finito che abbia un ciclo produttivo, non dipende da quanto complesso possa essere, costituito da lavorazioni con macchine, impianti o attrezzature e da manodopera piu o meno specializzata. Il ciclo deve essere strutturato in modo tale da poter essere interrotto in una certa fase e ripristinato, completato in un'altra azienda, in un'altra area, in una realta diversa in modo che ci嘆 comporti la possibilit di fornire localmente tale prodotto servizio: senza dover effettuare investimenti di capitale difficilmente ammortizzabili, indipendentemente da chi li effettua; senza dover formare del personale altamente specializzato in loco; senza dover cedere del know how di particolare rilevanza; senza dover cedere metodi e procedure coperte da segreto industriale o brevettate;]]>
P.D.P.D.P. PARTIAL DIAGNOSTIC PROCESS DELOCALISATION PROJECT TRANSPORT OF HUMAN BIOLOGICAL SAMPLES HIGH COST & DEPERIBILITY ANALYSIS Business develoment prospective Parziale Delocalizzazione Produttiva prodotti\servizi a cui e applicabile modalita operative A quali prodotti\servizi e applicabile. La delocalizzazione produttiva e applicabile ad ogni prodotto\servizio finito\semi finito che abbia un ciclo produttivo, non dipende da quanto complesso possa essere, costituito da lavorazioni con macchine, impianti o attrezzature e da manodopera piu o meno specializzata. Il ciclo deve essere strutturato in modo tale da poter essere interrotto in una certa fase e ripristinato, completato in un'altra azienda, in un'altra area, in una realta diversa in modo che ci嘆 comporti la possibilit di fornire localmente tale prodotto servizio: senza dover effettuare investimenti di capitale difficilmente ammortizzabili, indipendentemente da chi li effettua; senza dover formare del personale altamente specializzato in loco; senza dover cedere del know how di particolare rilevanza; senza dover cedere metodi e procedure coperte da segreto industriale o brevettate;]]> Sun, 07 Jan 2018 21:21:57 GMT /slideshow/pdpdp/85829745 robertoscarafia@slideshare.net(robertoscarafia) Pdpdp robertoscarafia P.D.P.D.P. PARTIAL DIAGNOSTIC PROCESS DELOCALISATION PROJECT TRANSPORT OF HUMAN BIOLOGICAL SAMPLES HIGH COST & DEPERIBILITY ANALYSIS Business develoment prospective Parziale Delocalizzazione Produttiva prodotti\servizi a cui e applicabile modalita operative A quali prodotti\servizi e applicabile. La delocalizzazione produttiva e applicabile ad ogni prodotto\servizio finito\semi finito che abbia un ciclo produttivo, non dipende da quanto complesso possa essere, costituito da lavorazioni con macchine, impianti o attrezzature e da manodopera piu o meno specializzata. Il ciclo deve essere strutturato in modo tale da poter essere interrotto in una certa fase e ripristinato, completato in un'altra azienda, in un'altra area, in una realta diversa in modo che ci嘆 comporti la possibilit di fornire localmente tale prodotto servizio: senza dover effettuare investimenti di capitale difficilmente ammortizzabili, indipendentemente da chi li effettua; senza dover formare del personale altamente specializzato in loco; senza dover cedere del know how di particolare rilevanza; senza dover cedere metodi e procedure coperte da segreto industriale o brevettate; <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/pdpdp-180107212157-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> P.D.P.D.P. PARTIAL DIAGNOSTIC PROCESS DELOCALISATION PROJECT TRANSPORT OF HUMAN BIOLOGICAL SAMPLES HIGH COST &amp; DEPERIBILITY ANALYSIS Business develoment prospective Parziale Delocalizzazione Produttiva prodotti\servizi a cui e applicabile modalita operative A quali prodotti\servizi e applicabile. La delocalizzazione produttiva e applicabile ad ogni prodotto\servizio finito\semi finito che abbia un ciclo produttivo, non dipende da quanto complesso possa essere, costituito da lavorazioni con macchine, impianti o attrezzature e da manodopera piu o meno specializzata. Il ciclo deve essere strutturato in modo tale da poter essere interrotto in una certa fase e ripristinato, completato in un&#39;altra azienda, in un&#39;altra area, in una realta diversa in modo che ci嘆 comporti la possibilit di fornire localmente tale prodotto servizio: senza dover effettuare investimenti di capitale difficilmente ammortizzabili, indipendentemente da chi li effettua; senza dover formare del personale altamente specializzato in loco; senza dover cedere del know how di particolare rilevanza; senza dover cedere metodi e procedure coperte da segreto industriale o brevettate;
Pdpdp from ToMa Advanced Biomedical Assays Spa
]]> 141 1 https://cdn.slidesharecdn.com/ss_thumbnails/pdpdp-180107212157-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://cdn.slidesharecdn.com/profile-photo-robertoscarafia-48x48.jpg?cb=1536481727 PreNatal Human Diagnostic - Cito-genetic, Molecular Biology and Pharmaco-genomic test - Innovative solution, professional training, www.tomalab.com https://cdn.slidesharecdn.com/ss_thumbnails/20180515tomaprivacygdprver10definitivaparte1-180521082548-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/20180515-toma-privacy-gdpr-ver10-definitiva-parte-1/97838542 20180515 toma privacy ... https://cdn.slidesharecdn.com/ss_thumbnails/20180426presentation-to-personnel-v3-180521080842-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/20180426-presentation-topersonnelv3pptx-97836493/97836493 20180426 presentation ... https://cdn.slidesharecdn.com/ss_thumbnails/20140211biocellteaser2-2014-180114205938-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/biocell-teaser-2-2014-roberto-scarafia-rscarafiatomalabcom/86141637 Biocell teaser 2 2014 ...